Test Price
2,800 AED✅ Home Collection Available
GCDH Gene Glutaric Acidemia Type 1 Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by certified genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview and Methodology
This Next-Generation Sequencing (NGS) based genetic test identifies pathogenic variants in the GCDH gene, definitively confirming diagnosis of Glutaric Acidemia Type 1 (GA1), a treatable metabolic disorder. The analysis uses high-depth coverage to detect single nucleotide variants and copy number changes with greater than 99.9% diagnostic sensitivity.
| Feature | Our GCDH NGS Test | Closest Alternative (Biochemical Testing) |
|---|---|---|
| Diagnostic Precision | Greater than 99.9% sensitivity; detects single nucleotide variants and copy number changes | Moderate; can miss mild or atypical presentations |
| Methodology | Next-Generation Sequencing (NGS) with high-depth coverage | Urine organic acid profile plus blood acylcarnitine panel |
| Turnaround Time | 3 to 4 weeks | 5 to 7 days |
| Clinical Utility | Confirms diagnosis, carrier screening, family risk assessment | Suggests GA1 but requires genetic confirmation |
Physician Insight and Safety Protocols
“As a Consultant Medical Genetics specialist, I recognize the profound impact of a confirmed genetic diagnosis. This NGS-based GCDH test provides definitive molecular evidence for Glutaric Acidemia Type 1, enabling timely dietary intervention and family counselling. Results must always be correlated with clinical presentation and metabolic markers for comprehensive patient management.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice: Medication Continuity
Do not discontinue any prescribed medication or dietary regimen without explicit guidance from your managing metabolic physician.
Safety Exclusion Criteria and Emergency Red Flags
- Exclusion Criteria: Acute intercurrent illness such as fever or active infection requires rescheduling. Inability to provide informed consent; for minors, a legal guardian must provide consent.
- Emergency Red Flags: If the patient experiences sudden vomiting, lethargy, seizures, or encephalopathy-like symptoms, discontinue test preparation and proceed to the nearest emergency room immediately.
Patient FAQ and Clinical Guidance
1. What is the GCDH gene test for Glutaric Acidemia Type 1 and who should consider it?
Answer: This NGS test detects GCDH mutations confirming Glutaric Acidemia Type 1 for targeted dietary management. Individuals with suggestive newborn screening results, unexplained neurological regression, macrocephaly, or a family history of GA1 should undergo this test. Carrier screening is recommended for relatives of affected patients.
2. How is the sample collected and what is the turnaround time?
Answer: A VIP Mobile Phlebotomist collects a blood sample or FTA card at your home via temperature-controlled cold-chain logistics, available daily from 8 AM to 11 PM across the UAE. Results are delivered within 3 to 4 weeks directly to your secure patient portal.
3. What legal and privacy protections apply to this genetic test in the UAE?
Answer: Testing adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored on DHA-compliant servers, and never shared without explicit consent. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
4. What are the key benefits of NGS over biochemical testing for GA1?
Answer: NGS provides definitive molecular confirmation with greater than 99.9% sensitivity, detects both single nucleotide variants and copy number changes, and enables carrier screening and family risk assessment. Biochemical testing alone can suggest GA1 but often misses mild or atypical cases and requires genetic confirmation.
UAE Regulatory and Data Privacy Adherence
This diagnostic service operates under the DHA Facility License Number 1143 and fully complies with the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted during transmission and at rest, stored on secure DHA-compliant servers, and accessible only to authorized medical personnel. Patient consent is obtained prior to sample collection, and clinical protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Results are delivered through a confidential channel with full transparency and respect for patient autonomy.
Clinical and Logistical Metadata
| Test Name | GCDH Gene Glutaric Acidemia Type 1 Genetic Test (NGS) |
| Price (AED) | AED 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, One Drop Blood on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with SNV and CNV analysis |
| ICD-10-CM Code | E72.3, Z14.8, Z15.89 |
| LOINC Code | 86586-2 |
| DHA Facility License and Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians